<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM UNAUDITED FINANCIAL STATEMENTS CONTAINED IN FORM 10-Q FOR THE QUARTER ENDING MARCH 31, 1995 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1995 <PERIOD-END> MAR-31-1995 <CASH> 911,200 <SECURITIES> 299,424 <RECEIVABLES> 1,476,948 <ALLOWANCES> 157,331 <INVENTORY> 465,549 <CURRENT-ASSETS> 3,284,526 <PP&E> 3,551,500 <DEPRECIATION> 2,006,701 <TOTAL-ASSETS> 6,314,399 <CURRENT-LIABILITIES> 1,489,957 <BONDS> 0 <COMMON> 11,728,301 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> (7,464,866) <TOTAL-LIABILITY-AND-EQUITY> 6,314,399 <SALES> 2,756,751 <TOTAL-REVENUES> 2,756,751 <CGS> 2,037,513 <TOTAL-COSTS> 2,037,513 <OTHER-EXPENSES> 773,544 <F1> <LOSS-PROVISION> 15,963 <INTEREST-EXPENSE> 8,346 <INCOME-PRETAX> (48,130) <INCOME-TAX> 0 <INCOME-CONTINUING> (48,130) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (48,130) <EPS-PRIMARY> (.01) <EPS-DILUTED> (.01) <FN> <F1> Other Expenses includes $283,632 in research and development expense and $489,912 in general and administrative expense. </FN>